3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Establishment Labs Holdings's 3-Year ROIIC % for the quarter that ended in Dec. 2025 was 5.05%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Establishment Labs Holdings's 3-Year ROIIC % or its related term are showing as below:
ESTA's 3-Year ROIIC % is ranked better than 55.57% of 799
companies
in the Medical Devices & Instruments industry
Industry Median: 1.67
vs ESTA: 5.05
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Establishment Labs Holdings 3-Year ROIIC % Related Terms
Establishment Labs Holdings 3-Year ROIIC % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ESTA vs AXGN, TMDX, BFLY: 3-Year ROIIC % Comparison
For the Medical Devices subindustry, Establishment Labs Holdings's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Establishment Labs Holdings 3-Year ROIIC % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Establishment Labs Holdings's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Establishment Labs Holdings's 3-Year ROIIC % falls into.
3-Year Incremental Net Operating Profit After Taxes (NOPAT)**
/
3-Year Incremental Invested Capital**
=
( -34.3309408 (Dec. 2025) - -39.658 (Dec. 2022) )
/
( 223.544 (Dec. 2025) - 117.998 (Dec. 2022) )
=
5.3270592
/
105.546
=
5.05%***
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Establishment Labs Holdings (ESTA) has a 3-Year ROIIC % of 5.05 as of Dec. 2025. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Establishment Labs Holdings and its competitors. According to the industry distribution chart, Establishment Labs Holdings ranks #355 out of 799 companies in the Medical Devices & Instruments industry, placing it in the top 44.4%.
Is Establishment Labs Holdings' 3-Year ROIIC % too high?
Establishment Labs Holdings' current 3-Year ROIIC % is 5.05. The Medical Devices & Instruments industry median 3-Year ROIIC % is 1.67. Establishment Labs Holdings' value of 5.05 is 202.4% above this industry median. Based on the distribution chart, Establishment Labs Holdings ranks #355 out of 799 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Establishment Labs Holdings has a GF Score™ of 71/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Establishment Labs Holdings' 3-Year ROIIC % compare to AXGN and TMDX?
According to the Medical Devices & Instruments industry distribution chart, Establishment Labs Holdings ranks #355 out of 799 companies for 3-Year ROIIC %. This puts Establishment Labs Holdings in the upper half of its industry. The industry median 3-Year ROIIC % is 1.67. Establishment Labs Holdings' value of 5.05 is 202.4% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Medical Devices & Instruments company?
The median 3-Year ROIIC % among Medical Devices & Instruments companies is 1.67, based on 799 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Establishment Labs Holdings's current 3-Year ROIIC % of 5.05 is 202.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Establishment Labs Holdings and its competitors. For the Medical Devices & Instruments industry, the median 3-Year ROIIC % is 1.67 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Establishment Labs Holdings's current 3-Year ROIIC % is 5.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Establishment Labs Holdings stock overvalued right now?
Based on GuruFocus' analysis, Establishment Labs Holdings (ESTA) is currently considered Significantly Overvalued. The stock's GF Value™ is $61.67, compared to a current price of $91.59 — trading 48.5% above its estimated fair value. The current 3-Year ROIIC % is 5.05 and 202.4% above the Medical Devices & Instruments industry median of 1.67. Establishment Labs Holdings' overall GF Score™ is 71/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Establishment Labs Holdings (ESTA), the current 3-Year ROIIC % is 5.05 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Establishment Labs Holdings (ESTA) Overvalued in 2026?
Based on GuruFocus' analysis, Establishment Labs Holdings stock appears to be overvalued.
The current stock price of $91.59 is trading 48.5% above its estimated GF Value™ of $61.67.
GuruFocus considers Establishment Labs Holdings to be Significantly Overvalued.
Key valuation signals for ESTA:
3-Year ROIIC %: 5.05
GF Value™: $61.67 vs. price of $91.59 (48.5% above fair value)
Industry Position: 202.4% above the Medical Devices & Instruments median (#355 of 799)
No single metric tells the full story. See the ESTA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Establishment Labs Holdings Inc is a medical technology company engaged in offering medical devices and aesthetic products. It is involved in the designing, manufacturing, and marketing of silicone-filled breast and body-shaping implants. The company markets its products under Motiva implants Brand. It distributes its products to medical distributors; and physicians, hospitals, and clinics in the form of direct sales. Its geographical segments are Europe, Latin America, Asia-Pacific/Middle East, and Others.
71GF Score
Get the complete analysis for ESTA
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ESTA has been successfully added to your 
